EnteroMedics (ETRM) Reports Q4 Loss of $2.65

EnteroMedics (NASDAQ: ETRM) reported Q4 EPS of ($2.65), versus ($66.70) reported last year. Revenue for the quarter came in at $141 thousand, versus $149 thousand reported last year.

For earnings history and earnings-related data on EnteroMedics (ETRM) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'